longbridge

Dermata Therapeutics

DRMA
----

All Shareholders

Shareholder Type

  • Public and others65.65%
  • Individuals & Insiders27.75%
  • Institutions6.39%
  • Private companies0.22%

Major Shareholders

Major Shareholders Latest
Shareholder
Gerald ProehlFounder, President, CEO & Chairman
21.45%862.87K4.23%+170.07K
Kyri Van HooseSenior VP & CFO
5.78%232.46K2.51%+101.08K
Bigger Capital, LLC
1.87%75.20K0.00%+0
Armistice Capital LLC
1.34%53.91K0.00%+0
Geode Capital Management, LLC
0.50%20.20K0.70%-28.13K
Welch & Forbes LLC
0.50%20.00K0.00%+0
Mary FisherFormer Independent Director
0.49%19.69K0.00%+0
State Street Investment Management
0.47%18.75K--+18.75K
UBS Asset Management AG
0.42%16.80K0.47%-18.81K
Susquehanna International Group, LLP
0.40%15.99K--+15.99K
XTX Markets Limited
0.37%14.79K--+14.79K
Advisory Alpha, LLC
0.25%10.00K--+10.00K
Hale BioPharma Ventures LLC
0.20%8.10K0.00%+0
Vanguard Capital Management, LLC
0.14%5.44K--+5.44K
Tower Research Capital Europe Limited
0.10%3.86K0.08%+3.14K
MCF Advisors, LLC
0.04%1.73K0.00%+0
Maria Bedoya-Toro
0.03%1.05K0.00%+0
Barclays Bank Plc
<0.01%270.00--+270.00
SBI Holdings, Inc.
<0.01%102.00<0.01%+1.00
David HaleCo-Founder & Lead Independent Director
<0.01%50.000.00%+0
© 2026 Longbridge｜Terms of ServicePrivacy Policy